Raymond James Financial Services Advisors’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$245K	Buy	1,348 +35	+3%	+$6.37K	﹤0.01%	3051
2024 Q2	$241K	Hold	1,313	–	–	﹤0.01%	3006
2024 Q1	$234K	Buy	+1,313	New	+$234K	﹤0.01%	3000